Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist

被引:0
|
作者
Mustafa Bahceci
Ulun Ulug
机构
[1] Bahceci Women Health Care Center,
[2] Bahceci Women Health Care Center and German Hospital in Istanbul,undefined
关键词
Progesterone; Vaginal; Intramuscular; IVF;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:499 / 502
页数:3
相关论文
共 50 条
  • [31] GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports
    Bakas, P.
    Boutas, I.
    Giner, M.
    Panagopoulos, P.
    Aravantinos, L.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2017, 44 (02): : 279 - 282
  • [32] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    Filho, J. S. Cunha
    Terres, L. F.
    Holanda, F.
    Freitas, F.
    Glitz, C.
    Genro, V. K.
    Arbo, E.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (08) : 326 - 330
  • [33] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    J. S. Cunha Filho
    L. F. Terres
    F. Holanda
    F. Freitas
    C. Glitz
    V. K. Genro
    E. Arbo
    Journal of Assisted Reproduction and Genetics, 2007, 24 : 326 - 330
  • [34] Comparison of GnRH agonist and antagonist protocols for controlled ovarian hyperstimulation (COH) in poor response IVF patients.
    Winston, NJ
    Puccini, M
    Nelson, L
    Scoccia, H
    FERTILITY AND STERILITY, 2004, 82 : S123 - S124
  • [35] Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial
    Zhang, Yisheng
    Liu, Liling
    Qin, Jie
    Huang, Hongyi
    Xue, Lintao
    Wang, Shikai
    Tan, Weihong
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [36] Evaluation of GnRH antagonist pretreatment before ovarian stimulation in a GnRH antagonist protocol in normal ovulatory women undergoing IVF/ICSI: a randomized controlled trial
    Yisheng Zhang
    Liling Liu
    Jie Qin
    Hongyi Huang
    Lintao Xue
    Shikai Wang
    Weihong Tan
    Reproductive Biology and Endocrinology, 19
  • [37] Is luteal phase support successfully performed using 25 mg/day of subcutaneous progesterone in controlled ovarian stimulation cycles with GnRH agonist triggering?
    Lara, E. E.
    Diaz-Gimeno, P.
    Casas, A. B.
    Garrigos, V.
    Ballesteros, A.
    HUMAN REPRODUCTION, 2016, 31 : 283 - 283
  • [38] Serum estradiol and progesterone in the mid-luteal phase predict clinical pregnancy outcome in IVF/ICSI cycles
    Sonntag, Barbara
    Loebbecke, Kay C.
    Nofer, Jerzy-Roch
    Kiesel, Ludwig
    Greb, Robert R.
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (07) : 700 - 703
  • [39] Different forms of vaginal progesterone for luteal phase support in IVF/ICSI cycles. A meta-analysis
    Tzioras, S.
    Polyzos, N. P.
    Messini, C. I.
    Papanikolaou, E. G.
    Valachis, A.
    Patavoukas, E.
    Mauri, D.
    Badawy, A.
    Messinis, I. E.
    HUMAN REPRODUCTION, 2010, 25 : I229 - I229
  • [40] The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
    Jing-Shuang Zhou
    Jian-Hong Chen
    Fei-Fei Tang
    Jian-Ping Ou
    Xin Tao
    Liu-Hong Cai
    BMC Pregnancy and Childbirth, 23